174 related articles for article (PubMed ID: 37144538)
21. Management of Small Bowel Neuroendocrine Tumors.
Scott AT; Howe JR
Surg Oncol Clin N Am; 2020 Apr; 29(2):223-241. PubMed ID: 32151357
[TBL] [Abstract][Full Text] [Related]
22. AACE/ACE disease state clinical review: diagnosis and management of midgut carcinoids.
Liu EH; Solorzano CC; Katznelson L; Vinik AI; Wong R; Randolph G
Endocr Pract; 2015 May; 21(5):534-545. PubMed ID: 25962092
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
Öberg K; Lamberts SW
Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
[TBL] [Abstract][Full Text] [Related]
24. Update on medical treatment of small intestinal neuroendocrine tumors.
Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
[TBL] [Abstract][Full Text] [Related]
25. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.
Boudreaux JP; Klimstra DS; Hassan MM; Woltering EA; Jensen RT; Goldsmith SJ; Nutting C; Bushnell DL; Caplin ME; Yao JC;
Pancreas; 2010 Aug; 39(6):753-66. PubMed ID: 20664473
[TBL] [Abstract][Full Text] [Related]
26. Principles of diagnosis and management of neuroendocrine tumours.
Raphael MJ; Chan DL; Law C; Singh S
CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
[No Abstract] [Full Text] [Related]
27. Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
Bolanowski M; Bednarczuk T; Bobek-Billewicz B; Handkiewicz-Junak D; Jeziorski A; Nowakowska-Duława E; Steinhof-Radwańska K; Zajęcki W; Zemczak A; Kos-Kudła B; ;
Endokrynol Pol; 2013; 64(6):480-93. PubMed ID: 24431119
[TBL] [Abstract][Full Text] [Related]
28. The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.
Shi W; Buchanan KD; Johnston CF; Larkin C; Ong YL; Ferguson R; Laird J
Clin Endocrinol (Oxf); 1998 Mar; 48(3):303-9. PubMed ID: 9578820
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
Perez K; Chan J
Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine Neoplasms of the Small Bowel and Pancreas.
Clift AK; Kidd M; Bodei L; Toumpanakis C; Baum RP; Oberg K; Modlin IM; Frilling A
Neuroendocrinology; 2020; 110(6):444-476. PubMed ID: 31557758
[TBL] [Abstract][Full Text] [Related]
31. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
[TBL] [Abstract][Full Text] [Related]
32. Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.
Poncet G; Faucheron JL; Walter T
World J Gastroenterol; 2010 Apr; 16(14):1696-706. PubMed ID: 20380000
[TBL] [Abstract][Full Text] [Related]
33. Advances in small bowel neuroendocrine neoplasia.
Banck MS; Beutler AS
Curr Opin Gastroenterol; 2014 Mar; 30(2):163-7. PubMed ID: 24441281
[TBL] [Abstract][Full Text] [Related]
34. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses.
de Herder WW; Lamberts SW
Curr Opin Oncol; 2002 Jan; 14(1):53-7. PubMed ID: 11790981
[TBL] [Abstract][Full Text] [Related]
36. [Neuroendocrine tumors of the small intestine and the appendix - management guidelines (recommended by The Polish Network of Neuroendocrine Tumors)].
Bolanowski M; Jarzab B; Handkiewicz-Junak D; Jeziorski A; Kos-Kudła B; Zajecki W;
Endokrynol Pol; 2008; 59(1):87-96. PubMed ID: 18335403
[TBL] [Abstract][Full Text] [Related]
37. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
[TBL] [Abstract][Full Text] [Related]
38. Gastroenteropancreatic Neuroendocrine Tumors.
Fernandes CJ; Leung G; Eads JR; Katona BW
Gastroenterol Clin North Am; 2022 Sep; 51(3):625-647. PubMed ID: 36153114
[TBL] [Abstract][Full Text] [Related]
39. Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Kipnis ST; Hung M; Kumar S; Heckert JM; Lee H; Bennett B; Soulen MC; Pryma DA; Mankoff DA; Metz DC; Eads JR; Katona BW
JAMA Netw Open; 2021 Mar; 4(3):e212274. PubMed ID: 33755166
[TBL] [Abstract][Full Text] [Related]
40. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]